Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Marceau

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The European Respiratory Journal|May 3, 2005
Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndromeO Brugière, G Thabut, H Mal, et al.
Bone Marrow Transplantation|January 10, 2017
Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AMLR Duléry, O Nibourel, J Gauthier, et al.
Leukemia|June 4, 2011
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemiaC Roche-Lestienne, A Marceau, E Labis, et al.
Leukemia Research|July 20, 2018
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine AC Kelaidi, T Braun, R Arana, et al.
Leukemia|November 20, 2015
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidineJ Desoutter, J Gay, C Berthon, et al.
Leukemia & Lymphoma|October 12, 2020
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter studyC Willekens, R Rahme, M Duchmann, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The European Respiratory Journal|May 3, 2005
Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndromeO Brugière, G Thabut, H Mal, et al.
Bone Marrow Transplantation|January 10, 2017
Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AMLR Duléry, O Nibourel, J Gauthier, et al.
Leukemia|June 4, 2011
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemiaC Roche-Lestienne, A Marceau, E Labis, et al.
Leukemia Research|July 20, 2018
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine AC Kelaidi, T Braun, R Arana, et al.
Leukemia|November 20, 2015
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidineJ Desoutter, J Gay, C Berthon, et al.
Leukemia & Lymphoma|October 12, 2020
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter studyC Willekens, R Rahme, M Duchmann, et al.
Pageof 2